Evidence map›Paper›PMID 40420861›Full record

ArticleFrontiers in plant science2025

Development of cleaved amplified polymorphic sequence marker for powdery mildew resistance in Korean malting barley using QTL-seq.

Jin-Cheon Park, Young-Mi Yoon, Chang-Hyun Lee, On-Sook Hur, Sang-Min Kim

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Extensive nrDNA Polymorphism inPlants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jin-Cheon ParkWinter Crop Research Division, Department of Crop Science, National Institute of Crop and Food Science, Rural Development Administration, Wanju, Republic of Korea.
Young-Mi YoonWinter Crop Research Division, Department of Crop Science, National Institute of Crop and Food Science, Rural Development Administration, Wanju, Republic of Korea.
Chang-Hyun LeeWinter Crop Research Division, Department of Crop Science, National Institute of Crop and Food Science, Rural Development Administration, Wanju, Republic of Korea.
On-Sook HurWinter Crop Research Division, Department of Crop Science, National Institute of Crop and Food Science, Rural Development Administration, Wanju, Republic of Korea.
Sang-Min KimCrop Environment Research Division, Department of Crop Science, National Institute of Crop and Food Science, Rural Development Administration, Wanju, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Powdery mildew (PM) caused by Methods: This study was conducted from 2022 to 2024 at the National Institute of Agricultural Sciences in Wanju, Republic of Korea. We conducted artificial crossing, genomic DNA extraction, phenotypic evaluation, QTL-seq analysis, and cleaved amplified polymorphic sequence (CAPS) marker development. Candidate gene expression was analyzed using real-time quantitative reverse transcription PCR. Results: A total of 2,130 common variants were identified in two regions of chromosome 1H (6,940,595-18,008,713 bp and 19,363,700-20,551,018 bp). Twenty-one non-synonymous single nucleotide polymorphisms among these variants were used to develop CAPS markers, which were validated in an F Conclusion: The development of the CAPS marker (PMC_75) provides a valuable tool for marker-assisted selection in breeding PM-resistant malting barley, improving breeding efficiency, and accelerating the development of resistant cultivars.

Indexed as

candidate genemalting barleymolecular markerpowdery mildewQTL-seqresistance

Identifiers

PMID40420861
PMCPMC12104202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.